Epsilon M&A Deal Report - Intervet Schering-Plough Animal Health
Transaction Multiples for the Valuation of Private Companies
Merck & Co / Intervet Schering-Plough Animal Health
No EMAT :
22046
Announced Date :
08/03/2009
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Merck & Co
Target :
Intervet Schering-Plough Animal Health
Country :
Netherlands
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Veterinary Pharmaceuticals
Business Description :
Intervet/Schering-Plough Animal Health develops, manufactures, and markets veterinary vaccines and pharmaceutical products . Through its own biopharmaceutical research and collaborations with...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|||
| Current |
|
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Veterinary Pharmaceuticals » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 12/03/2007 | Schering-Plough | Organon BioSciences (OBS) | Netherlands | ** | 22045 |
| 19/10/2010 | Orpea | Mediter Group and Medibelge Group | Belgium | ** | 22037 |
Source: Epsilon Research / EMAT
